Ending The Diagnostic Odyssey with Josh Resnikoff

Ending the Diagnostic Odyssey: Rare Disease, Employers & Reimagining Health Plans

Hosts: Na-Ri Oh & Ian WendtGuest: Joshua Resnikoff, Founder & CEO, Sunstone Health

Episode Overview

What if the biggest innovation in rare disease wasn’t a new drug—but a new way to navigate the system?

In this episode, Na-Ri and Ian sit down with Joshua Resnikoff, biomedical engineer turned founder of Sunstone Health, to explore how employers can fundamentally rethink healthcare spending—while dramatically improving outcomes for families facing rare diseases.

Josh’s journey into healthcare reform wasn’t academic—it was personal. After years navigating the healthcare system to diagnose his son’s rare periodic fever syndrome, Josh experienced firsthand the emotional, financial, and systemic toll of what’s known as the diagnostic odyssey. That experience sparked a mission: compress a seven-year diagnostic journey into just 12 weeks.

This conversation dives into rare disease, employer-sponsored health plans, insurance mechanics, and why aligning incentives might be the key to transforming care.

🔬 From Scientist to System Builder

Josh’s background as a biomedical engineer at Harvard’s Wyss Institute

The rare disease journey that reshaped his career

Why getting a diagnosis—even without treatment—changes everything

The emotional and economic cost of delayed diagnosis